Reena Shakya, Ph.D.
Affiliations: | 2005 | Columbia University, New York, NY |
Area:
Genetics, Molecular BiologyGoogle:
"Reena Shakya"Parents
Sign in to add mentor| Frank Costantini | grad student | 2005 | Columbia | |
| (The role of GDNF /Ret and FGF7/FGFR2IIIb signaling in the development of the excretory system.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dauch C, Shim S, Cole MW, et al. (2022) loss drives aggressive tumor phenotypes in cutaneous squamous cell carcinoma. American Journal of Cancer Research. 12: 1309-1322 |
| Purde V, Kudryashova E, Heisler DB, et al. (2020) Intein-mediated cytoplasmic reconstitution of a split toxin enables selective cell ablation in mixed populations and tumor xenografts. Proceedings of the National Academy of Sciences of the United States of America |
| Park D, Bergin SM, Jones D, et al. (2020) Ablation of the Brca1-Palb2 interaction phenocopies Fanconi anemia in mice. Cancer Research |
| Choueiry F, Torok M, Shakya R, et al. (2020) CD200 promotes immunosuppression in the pancreatic tumor microenvironment. Journal For Immunotherapy of Cancer. 8 |
| Geisler JA, Spehar JM, Steck SA, et al. (2020) Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging. Journal of Visualized Experiments : Jove |
| Park D, Shakya R, Koivisto C, et al. (2019) Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains. Plos One. 14: e0226714 |
| Seligson ND, Stets CW, Demoret BW, et al. (2019) Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma. Oncotarget. 10: 5671-5679 |
| Ware MB, McQuinn C, Mace TA, et al. (2019) Abstract B59: IL-6 regulates CTLA4 expression on CD4+ T-cells and dual antibody blockade of IL-6 and CTLA4 leads to tumor regression in an orthotopic murine model of pancreatic ductal adenocarcinoma Cancer Research. 79 |
| Spaeth-Cook D, Burch M, Belton R, et al. (2018) Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition. Oncotarget. 9: 35676-35686 |
| Farren MR, Hennessey RC, Shakya R, et al. (2017) The exportin-1 inhibitor selinexor exerts superior anti-tumor activity when combined with T cell checkpoint inhibitors. Molecular Cancer Therapeutics |